156 related articles for article (PubMed ID: 34549395)
1. Determinants for Control of Status Epilepticus in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Yen HK; Tang SC; Tsai LK; Fan SP; Yeh SJ; Jeng JS
Acta Neurol Taiwan; 2021 Mar; 30(1)():1-10. PubMed ID: 34549395
[TBL] [Abstract][Full Text] [Related]
2. Seizure outcomes in patients with anti-NMDAR encephalitis: A follow-up study.
Liu X; Yan B; Wang R; Li C; Chen C; Zhou D; Hong Z
Epilepsia; 2017 Dec; 58(12):2104-2111. PubMed ID: 29098690
[TBL] [Abstract][Full Text] [Related]
3. Seizure Characteristics, Outcome, and Risk of Epilepsy in Pediatric Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
Qu XP; Vidaurre J; Peng XL; Jiang L; Zhong M; Hu Y
Pediatr Neurol; 2020 Apr; 105():35-40. PubMed ID: 31917096
[TBL] [Abstract][Full Text] [Related]
4. Status Epilepticus in Patients with Anti-NMDAR Encephalitis Requiring Intensive Care: A Follow-Up Study.
Wang X; Wan J; Wei Z; Song C; Kang X; Du F; Jiang W; Yang F
Neurocrit Care; 2022 Feb; 36(1):192-201. PubMed ID: 34286465
[TBL] [Abstract][Full Text] [Related]
5. Long-term and Strong Immunotherapy to Treat Anti-N-Methyl- D-Aspartate Receptor Encephalitis with Refractory Status Epilepticus.
Lee LH; Lu CJ
Acta Neurol Taiwan; 2016 Sep; 25(3):99-103. PubMed ID: 27854088
[TBL] [Abstract][Full Text] [Related]
6. Characterization and Outcomes of Epileptic Seizures in Mexican Pediatric Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis.
Chavez-Castillo M; Ruiz-Garcia M; Herrera-Mora P
Cureus; 2020 May; 12(5):e8211. PubMed ID: 32577329
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABA
de Bruijn MAAM; van Sonderen A; van Coevorden-Hameete MH; Bastiaansen AEM; Schreurs MWJ; Rouhl RPW; van Donselaar CA; Majoie MHJM; Neuteboom RF; Sillevis Smitt PAE; Thijs RD; Titulaer MJ
Neurology; 2019 May; 92(19):e2185-e2196. PubMed ID: 30979857
[TBL] [Abstract][Full Text] [Related]
8. Simple and effective serum biomarkers potential for predicting status epilepticus in anti-N-methyl-D-aspartate receptor encephalitis.
Liu Y; Ma L; Ma X; Ma X; Li J; Li D; Lin X; Su Z; Chen X
BMC Neurol; 2022 Jan; 22(1):27. PubMed ID: 35031011
[TBL] [Abstract][Full Text] [Related]
9. EEG extreme delta brush: An ictal pattern in patients with anti-NMDA receptor encephalitis.
Veciana M; Becerra JL; Fossas P; Muriana D; Sansa G; Santamarina E; Gaig C; Carreño M; Molins A; Escofet C; Ley M; Vivanco R; Pedro J; Miró J; Falip M;
Epilepsy Behav; 2015 Aug; 49():280-5. PubMed ID: 26071995
[TBL] [Abstract][Full Text] [Related]
10. Early polytherapy for benzodiazepine-refractory status epilepticus.
Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG
Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007
[TBL] [Abstract][Full Text] [Related]
11. Associations between seizures and MRI in patients with anti-NMDAR encephalitis.
Ni G; Lin W; Cai X; Qin J; Feng L; Zhu S; Zhou L; Chen Z
Acta Neurol Scand; 2020 Nov; 142(5):460-465. PubMed ID: 32533702
[TBL] [Abstract][Full Text] [Related]
12. New Onset Focal Seizure Clusters in Children: Expanding the Spectrum of Anti NMDAR Encephalitis.
Roy AG; Vinayan KP; Kannoth S
Neurol India; 2020; 68(6):1374-1377. PubMed ID: 33342871
[TBL] [Abstract][Full Text] [Related]
13. Anti-N-methyl-D-aspartate receptor encephalitis with favorable outcome despite prolonged status epilepticus.
Finné Lenoir X; Sindic C; van Pesch V; El Sankari S; de Tourtchaninoff M; Denays R; Hantson P
Neurocrit Care; 2013 Feb; 18(1):89-92. PubMed ID: 23090840
[TBL] [Abstract][Full Text] [Related]
14. Long-term seizure outcome in patients with status epilepticus due to acute encephalitis.
Leng X; Yuan F; Zhao J; Song C; Zhao Z; Zhang Y; Gao Q; Yang F; Jiang W
Seizure; 2019 Jul; 69():70-75. PubMed ID: 30981052
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Seizure and Antiepileptic Drug Utilization in Outpatients With Autoimmune Encephalitis.
Huang Q; Ma M; Wei X; Liao Y; Qi H; Wu Y; Wu Y
Front Neurol; 2018; 9():1136. PubMed ID: 30671012
[TBL] [Abstract][Full Text] [Related]
16. Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis presenting to the emergency department with status epilepticus.
Nolan B; Plenk K; Carr D
CJEM; 2014 Sep; 16(5):425-8. PubMed ID: 25227654
[TBL] [Abstract][Full Text] [Related]
17. Clinical and electrographic features of persistent seizures and status epilepticus associated with anti-NMDA receptor encephalitis (anti-NMDARE).
Gofshteyn JS; Yeshokumar AK; Jette N; Thakur KT; Luche N; Yozawitz E; Varnado S; Klenofsky B; Tuohy MC; Ankam J; Torres S; Hesdorffer D; Nelson A; Wolf S; McGoldrick P; Yan H; Basma N; Grinspan Z
Epileptic Disord; 2020 Dec; 22(6):739-751. PubMed ID: 33258455
[TBL] [Abstract][Full Text] [Related]
18. Seizure characteristics, treatment, and outcome in autoimmune synaptic encephalitis: A long-term study.
Zhang W; Wang X; Shao N; Ma R; Meng H
Epilepsy Behav; 2019 May; 94():198-203. PubMed ID: 30974347
[TBL] [Abstract][Full Text] [Related]
19. Status epilepticus in encephalitis: a study of clinical findings, magnetic resonance imaging, and response to antiepileptic drugs.
Kalita J; Nair PP; Misra UK
J Neurovirol; 2008 Oct; 14(5):412-7. PubMed ID: 18989815
[TBL] [Abstract][Full Text] [Related]
20. Clinical Features, Treatment, and Outcomes Among Chinese Children With Anti-methyl-D-aspartate Receptor (Anti-NMDAR) Encephalitis.
Zhang M; Li W; Zhou S; Zhou Y; Yang H; Yu L; Wang J; Wang Y; Zhang L
Front Neurol; 2019; 10():596. PubMed ID: 31244759
[No Abstract] [Full Text] [Related]
[Next] [New Search]
